$1.5B
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | ORKA Oruka Therapeutics Inc | 3.7M | +0.0% | $353M | 23.3% |
| 2 | DNTH Dianthus Therapeutics Inc | 2.5M | +0.0% | $247M | 16.3% |
| 3 | DMRA Damora Therapeutics Inc | 8.7M | +0.0% | $227M | 15.0% |
| 4 | COGT Cogent Biosciences Inc | 5.5M | +0.0% | $213M | 14.1% |
| 5 | JBIO Jade Biosciences Inc | 4.6M | +0.0% | $101M | 6.7% |
| 6 | ELVN Enliven Therapeutics Inc | 1.9M | +0.0% | $94M | 6.2% |
| 7 | VRDN Viridian Therapeutics Inc | 5.1M | +30.1% | $94M | 6.2% |
| 8 | ZBIO Zenas Biopharma Inc | 2.4M | +0.0% | $60M | 4.0% |
| 9 | CBIO Crescent Biopharma Inc. | 2.7M | +0.0% | $49M | 3.3% |
| 10 | APOGEE THERAPEUTICS INC Apogee Therapeutics Inc | 298,647 | +0.0% | $40M | 2.6% |
| 11 | FTH Faeth Therapeutics Inc | 722,020 | — | $18M | 1.2% |
| 12 | IKT Inhibikase Therapeutics Inc | 8.6M | +0.0% | $18M | 1.2% |